Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Reports Full-Year 2019 Preliminary Revenue of $421.0 Million

PARSIPPANY, N.J., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), a leading provider of innovative non-opioid pain management options, today reported preliminary unaudited...
January 08, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 38th Annual J.P. Morgan Healthcare Conference at 9:30 AM PT...
January 07, 2020 07:30 ET | Source: Pacira BioSciences

EXPAREL Achieves Primary and Key Secondary Endpoints in Phase 4 CHOICE Study in Cesarean Section Patients

PARSIPPANY, N.J., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that its Phase 4 study of EXPAREL® (bupivacaine liposome injectable suspension) in...
December 17, 2019 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Announces Positive Results from Phase 3 PLAY Study of EXPAREL® in Pediatric Patients

PARSIPPANY, N.J., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today announced positive results...
November 26, 2019 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences to Present at the 31st Annual Piper Jaffray Healthcare Conference

PARSIPPANY, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 31st Annual Piper Jaffray Healthcare Conference at 9:30 AM on...
November 13, 2019 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences to Present at the Jefferies 2019 London Healthcare Conference

PARSIPPANY, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the Jefferies 2019 London Healthcare Conference at 2:40 PM GMT...
November 07, 2019 08:00 ET | Source: Pacira BioSciences

Pacira BioSciences Reports Third Quarter 2019 Financial Results and Business Update

-- Total revenues increased 25 percent over prior year to $104.7 million in third quarter -- -- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Pacira...
October 25, 2019 07:30 ET | Source: Pacira BioSciences

Pacira to Report Third Quarter 2019 Financial Results on Thursday November 7, 2019

PARSIPPANY, N.J., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets...
September 19, 2019 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Appoints Chris Christie to Board of Directors

PARSIPPANY, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today announced the appointment of...
September 17, 2019 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Completes Enrollment in Multicenter Registration Study of EXPAREL® in Pediatric Patients

PARSIPPANY, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today announced that it has reached...